Summary: Nvidia CEO Jensen Huang emphasizes the importance of building a strong channel presence to scale AI business and bring AI solutions to the enterprise market.
Full articleSummary: Caterpillar's price target raised to $335.00 by Barclays with an 'equal weight' rating, potential upside of 2.46% from the previous close. Insiders sold shares recently. Company's board authorized a $20.00 billion share buyback program.
Full articleSummary: Amgen reports a 1% decrease in second-quarter profit due to higher expenses related to the development of the obesity drug MariTide, despite a 20% increase in revenue driven by the acquisition of Horizon Therapeutics. The company is focusing on progress with MariTide and plans to launch a Phase 3 program for the drug soon.
Full articleSummary: Arijit Roy appointed to U.S. Bank Managing Committee, a group of top leaders with various responsibilities to drive ongoing growth.
Full articleSummary: A man is facing charges after allegedly leading police on a chase in a stolen FedEx truck which was disabled of its GPS system and onboard surveillance cameras.
Full articleSummary: JPMorgan Chase & Co. has crossed the notification threshold of 5.067655% in Trident Royalties PLC, signaling a strong vote of confidence in the company.
Full articleSummary: IBM could be a good stock pick from a technical perspective after surpassing resistance at the 20-day moving average, suggesting a short-term bullish trend. Positive earnings estimate revisions also support a bullish case.
Full articleSummary: CVS Health had a second-quarter earnings call with updates provided by Karen S. Lynch, President and CEO, and Tom Cowhey, CFO. They reported adjusted earnings per share of $1.83, updated full-year 2024 adjusted EPS guidance, and discussed various business segments' performances. Changes in leadership were announced for the Health Care Benefits segment. CVS Health is focused on achieving cost savings, driving improved financial and operational performance, and providing value to customers.
Full articleSummary: McDonald's introduces a new Collector’s Meal promotion featuring six cups showcasing past marketing tie-ins and collaborations, aiming to tap into customer nostalgia for the brand.
Full articleSummary: Samsung's HBM3E chips have passed Nvidia's tests for AI processors, paving the way for a supply deal expected to start in Q4 2024.
Full articleSummary: Arijit Roy joins U.S. Bancorp Managing Committee to lead Consumer and Business Banking product organization, focusing on driving growth and enhancing capabilities.
Full articleSummary: Origis Energy closed a $71 million tax equity financing deal with U.S. Bancorp Impact Finance to support the Rice Creek Solar project in Florida.
Full articleSummary: Joseph Robert Meyer JR, SVP & Chief Accounting Officer at American Tower, executed a substantial insider sell by selling 2,181 shares worth $508,020. American Tower's shares are up by 0.49%.
Full articleSummary: Rashida La Lande will join The Estée Lauder Companies as executive vice president and general counsel after serving in a similar role at The Kraft Heinz Company since 2018.
Full articleSummary: Costco is implementing new membership scanning devices at all entrances, requiring members to scan their card for entry and guests to be accompanied by a member to gain access.
Full articleSummary: NVIDIA will host a conference call to discuss its financial results for the second quarter of fiscal year 2025 on August 28, 2024. Ahead of the call, written commentary by the CFO will be posted on the company's website.
Full articleSummary: Class action lawsuit reminder against CVS Health Corporation for securities violations by The Schall Law Firm
Full articleSummary: Citigroup Inc (C) was held by 12 out of the 24 most recent 13F filings for the 06/30/2024 reporting period.
Full articleSummary: Microsoft has contracted Samsung to supply micro OLED display panels for next-generation mixed reality devices, potentially competing with Apple Vision Pro. Other tech giants like Meta, Samsung, and Google are also gearing up to compete in the XR market.
Full articleSummary: Mizuho Securities analyst Haendel St. Juste maintains a neutral stance on SPG stock due to a combination of factors impacting Simon Property Group, including strong second-quarter results, signs of plateauing in portfolio sales and rents, and acknowledgment of potential recession risks by management.
Full articleSummary: Analyst Sarah Akers maintains a Hold rating on Transdigm Group with a price target of $1,350.00. Multiple analysts have varying ratings on the stock, with insider sentiment being negative due to increased selling by insiders.
Full articleSummary: Walt Disney (DIS) held its Q3 2024 earnings call with a new format of only Q&A session. Topics discussed included theme parks, NBA deal, Disney+, and strategic partnerships for ESPN. The company highlighted strong ad market health and content licensing success. The outlook for Disney+ remains bullish with a focus on continued subscriber growth and pricing power.
Full articleSummary: Rising claims from the company's Medicare Advantage coverage have hurt CVS Health for much of this year and contributed to repeated trimmings of its outlook for 2024.
Full articleSummary: Pepsico Beverages North America has opened a distribution center in Smyrna
Full articleSummary: Tesla has cancelled plans to set up an EV factory in Thailand, Malaysia or Indonesia and will focus solely on setting up charging stations, following a layoff of the executive team. Tesla has decided to cancel such plans across Asia and beyond, including disbanding the executive team. The ASEAN race to lure Tesla's business is over.
Full articleSummary: Meta integrates Meta AI chatbot into WhatsApp, Instagram, and Facebook Messenger in India, powered by Llama 3 for image generation capabilities.
Full articleSummary: 1. Amgen Inc. reported strong second-quarter results with 20% revenue growth across various medicines, including in-market portfolio, rare diseases, and oncology. Robust performance was driven by volume growth and positive reception of key drugs like Repatha, EVENITY, and BLINCYTO. 2. The company is confident in its long-term growth outlook, with a focus on innovation and capital allocation priorities. They have initiated activities to further expand MariTide manufacturing capacity and are committed to retiring debt by the end of 2025. 3. Forward-looking statements were made regarding the potential of MariTide in obesity, obesity-related conditions, and type 2 diabetes, with plans for a broad Phase III program, and the progress and insights gained from R&D efforts in rare diseases were highlighted.
Full article